Mills Peninsula Medical Center — Burlingame, California

Public research footprint of Mills Peninsula Medical Center, compiled from the ClinicalTrials.gov public registry.

136

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Neuroendocrine Neoplasm · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Ovarian Carcinoma · Neuroendocrine Tumor G2

Recently updated registry entries

NCT00588770 — Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or… (Active Not Recruiting)
NCT02257528 — Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer (Active Not Recruiting)
NCT02048813 — Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mills Peninsula Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.